Inclusion of multiple high‐risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma

AIMS: The decision to consider adjuvant chemotherapy (AC) for non‐small cell lung cancer is currently governed by clinical stage. This study aims to assess other routinely collected pathological variables related to metastasis and survival for their ability to predict the efficacy of AC in lung aden...

Descripción completa

Detalles Bibliográficos
Autores principales: Sereno, Marco, He, Zhangyi, Smith, Claire R, Baena, Juvenal, Das, Madhumita, Hastings, Robert K, Rake, Grace, Fennell, Dean A, Nakas, Apostolos, Moore, David A, Le Quesne, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247971/
https://www.ncbi.nlm.nih.gov/pubmed/33155719
http://dx.doi.org/10.1111/his.14301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247971/
https://www.ncbi.nlm.nih.gov/pubmed/33155719
http://dx.doi.org/10.1111/his.14301

Ejemplares similares